Streetbeat News

Analyst Ratings

HALO

Goldman Sachs analyst Graig Suvannavejh has maintained a Neutral rating on Halozyme Therapeutics (NASDAQ:HALO) but reduced the price target from $45 to $40.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:50 pm

VRNS

DA Davidson analyst Rishi Jaluria has downgraded Varonis Systems (NASDAQ:VRNS) from Buy to Neutral, while increasing the price target from $37 to $45.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:47 pm

EHTH

Craig-Hallum analyst George Sutton has downgraded eHealth (NASDAQ:EHTH) from Buy to Hold while maintaining the price target at $7. This reflects a neutral stance on the stock's near-term growth prospects.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:45 pm

GRAB

JP Morgan has upgraded Grab's stock from Neutral to Overweight and increased the price target from $3.6 to $3.8, resulting in a positive trading performance for Grab shares.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:43 pm

MCHP

Microchip Technology's stock (MCHP) is trading higher following an upgrade from Wolfe Research, which changed its rating from Peer Perform to Outperform and set a price target of $105.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:42 pm

NXPI

NXP Semiconductors' stock (NXPI) has been upgraded by Wolfe Research from Peer Perform to Outperform, with a new price target set at $255. This upgrade suggests a positive outlook on the company's performance and potential growth.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:40 pm

WTFC

Wedbush analyst David Chiaverini has reiterated an Outperform rating on Wintrust Financial Corporation (NASDAQ:WTFC) and maintained a price target of $110. This reaffirmation of the positive outlook for WTFC suggests confidence in the company's performance and potential for stock price growth.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:36 pm

SLB

Schlumberger Ltd (NYSE:SLB) is set to release its Q4 earnings on January 19. Wall Street anticipates an EPS of 84 cents and revenue of $8.96 billion. Analysts will focus on the company's positioning against challenges like the end of OPEC supply cuts and economic weaknesses. Schlumberger's growth prospects, declining debt, and positive industry outlook for 2024 are noted, despite a limited dividend history. The stock is rated as a Buy with a price target between $68 and $77, while currently trading at $47.89.

Portfolio Pulse from Surbhi Jain

January 18, 2024 | 1:34 pm

AMD

MSFT

NVDA

TSLA

Jim Cramer predicts Tesla (TSLA) may be the first to fall among the 'Magnificent Seven' stocks due to CEO Elon Musk's recent comments about needing more voting control. Cramer contrasts this with his positive view on Nvidia (NVDA) and its CEO. The article also notes that tech stocks, including Nvidia, Microsoft (MSFT), and Advanced Micro Devices (AMD), have had a rocky start to the year but are favored by analysts for their AI capabilities. Tesla faces challenges with slowing EV adoption and price cuts impacting its bottom line.

Portfolio Pulse from Shanthi Rexaline

January 18, 2024 | 1:25 pm

VOR

Wedbush analyst David Nierengarten has reiterated an Outperform rating on Vor Biopharma (NASDAQ:VOR) and maintained a price target of $11. The reaffirmation of the rating and price target suggests confidence in the company's prospects.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:24 pm